These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 1255776)
21. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat. Ito N; Fukushima S; Shirai T; Nakanishi K Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032 [TBL] [Abstract][Full Text] [Related]
22. Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with n-butyl-n-(4-hydroxybutyl)nitrosamine. Nakanishi K; Hirose M; Ogiso T; Hasegawa R; Arai M; Ito N Gan; 1980 Aug; 71(4):490-500. PubMed ID: 7429086 [TBL] [Abstract][Full Text] [Related]
23. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839 [TBL] [Abstract][Full Text] [Related]
24. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158 [TBL] [Abstract][Full Text] [Related]
25. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer]. Okajima E; Hiramatsu T; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Tanaka M; Maruyama Y Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898 [TBL] [Abstract][Full Text] [Related]
26. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters. Hashimura T; Kanamaru H; Yoshida O Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979 [TBL] [Abstract][Full Text] [Related]
28. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine. Fujita J; Yoshida O; Fujita H; Mikuni I Tokai J Exp Clin Med; 1983 Nov; 8(4):359-63. PubMed ID: 6679940 [TBL] [Abstract][Full Text] [Related]
29. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine]. Samma S; Tabata S; Nakatsuji F; Yoshie T; Moriya A; Matsuki H; Watanabe S; Babaya K; Hirao Y; Okajima E Gan To Kagaku Ryoho; 1985 Aug; 12(8):1661-8. PubMed ID: 3927848 [TBL] [Abstract][Full Text] [Related]
30. Effect of 1-hexylcarbamoyl-5-fluorouracil on development of rat urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Ozono S; Iwata H; Tsunemi K; Takahashi S; Matsuki H; Sasaki K; Hirao Y; Okajima E Jpn J Exp Med; 1988 Jun; 58(3):123-7. PubMed ID: 3184501 [TBL] [Abstract][Full Text] [Related]
31. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine. Hirose M; Murasaki G; Imaida K; Fukushima S; Ito N Gan; 1980 Oct; 71(5):729-32. PubMed ID: 7227722 [TBL] [Abstract][Full Text] [Related]
32. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder. Suzuki E; Iiyoshi M; Okada M Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637 [TBL] [Abstract][Full Text] [Related]
33. Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. Fukushima S; Shibata M; Tamano S; Ito N; Suzuki E; Okada M J Natl Cancer Inst; 1987 Aug; 79(2):263-7. PubMed ID: 3474459 [TBL] [Abstract][Full Text] [Related]
34. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine. Suzuki E; Mochizuki M; Okada M Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694 [TBL] [Abstract][Full Text] [Related]
35. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat. Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665 [TBL] [Abstract][Full Text] [Related]
36. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats. Fukushima S; Murasaki G; Hirose M; Nakanishi K; Hasegawa R; Ito N Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816 [TBL] [Abstract][Full Text] [Related]
37. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102 [TBL] [Abstract][Full Text] [Related]
38. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats. Shirai T Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054 [TBL] [Abstract][Full Text] [Related]
39. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine. McCormick DL; Ronan SS; Becci PJ; Moon RC Carcinogenesis; 1981; 2(3):251-4. PubMed ID: 7273310 [TBL] [Abstract][Full Text] [Related]
40. Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Tamano S; Fukushima S; Shirai T; Hirose M; Ito N Cancer Lett; 1987 Apr; 35(1):39-46. PubMed ID: 3567886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]